Dr Yong Du (m)

Consultant in Nuclear Medicine and PET/CT

QualificationsMBBS MSc PhD FRCP

GMC number:


Clinical interests:

  • Nuclear medicine: both diagnostic and theraputic
  • PET/CT imaging
  • Radionuclide targeted therapies: bone metastases, lymphoma, NET, thyrotoxicosis and thrombocytosis
  • SPECT & SPECT/CT imaging

Fees, Training & Background:

Dr Yong Du graduated from Shandong Medical University and was awarded a PhD in Cancer Sciences at University of Southampton for his work on lymphoma.

Dr Du completed his nuclear medicine specialist training at the Institute of Nuclear Medicine, University College Hospital in London. He was the first recipient of the national HEFCE Clinical Senior Lectureship Award in the Nuclear Medicine specialty, awarded in June 2009.

In conjunction with his clinical practice, he has research interests to further assess the role, efficacy and limitations of PET CT in various cancers, to optimise its use, and inform tailored treatments for patients.

Dr Yong Du also has extensive experience in radionuclide targeted therapy. He is interested in combining the fast advancing functional imaging technology with multidisciplinary expertise to help develop and optimise radionuclide targeted therapy for cancer patients.

In collaboration with researchers across the country, Dr Yong Du has led and contributed to a number of international and national studies, has published first-authored research papers in high-impact oncology journals including Journal of Clinical Oncology, Blood and Cancer Research.

Clinic Times

Clinic Times: By appointment only

Main NHS base:

  • The Royal Marsden NHS Foundation Trust

Member of:

  • Trustee of the British Nuclear Medicine Society
  • French AERES Committee
  • NCRI PET Research Network
  • BNMS Radionuclide Targeted Therapy Committee
  • NCRI Clinical and Translational Radiotherapy (CTRad) Research Working Group